Posted in | News | Aerospace Robotics

Lockheed Martin and Partners to Explore Advanced Autonomous Technologies for Unmanned Air System

The Office of Naval Research has awarded a $13.5 million contract to an industry team led by Lockheed Martin to explore highly advanced autonomous technologies aboard an unmanned vertical take-off and landing aircraft.

Under the contract, Lockheed Martin and a team of industry, government, and academic partners will develop a technology that will enable aircraft to operate under supervisory control. A human operator will interact with the system at a high level while low level control is left to the automation.

The resulting technology will have the potential to improve the utility and effectiveness of current unmanned vertical take-off and landing aircraft, as well as offer pilots supplemental decision aids on legacy manned platforms.

"This contract provides our team the opportunity to demonstrate how far we can expand the technology envelope," said Roger Il Grande, director of Airborne Systems for Lockheed Martin's Mission Systems & Sensors business. "Some of our cutting edge technology has already been demonstrated on K-MAX for the Army's Autonomous Technologies for Unmanned Air System program, and is now deployed with the Marine Corps on the aircraft in Afghanistan."

During this first, 18-month phase of the five-year effort, the team will demonstrate the capabilities of its Open-Architecture Planning and Trajectory Intelligence for Managing Unmanned Systems (OPTIMUS) architecture. OPTIMUS is designed to be platform-agnostic, drawing from Lockheed Martin's experience with the unmanned K-MAX cargo resupply program and the combined teams' expertise in the fields of sensing, autonomy and human-machine interaction.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.